Argent Biopharma Limited has released a press release.
Study Results - Effects of CannEpil on driving performance
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- US$1.2M Tranche 1 Funding Recevied from Mercer
- US$10M Financing Agreement signed with US Financier/Investor
- Strategic Acquisition of 40% interest in ZAM Software Ltd
- Amended June Quarterly Reports (amended App. 4C)
- June Quarter Activities and Cash Flow Report
Later from Argent Biopharma
- AMC Holdings Inc places US$1 million ArtemiC order
- US$750,000 Convertible Note Facility Funding
- Interim Results - CimetrA Dosing Finding Study
- US$550,000 Convertible Note Facility Funding
- TGA advertising Infringement Notice
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma